Physiology and pathophysiology of pleural fluid turnover

The pleural space contains a tiny amount (approximately 0.3 mL.kg-1) of hypooncotic fluid (approximately 1 g.dL-1 protein). Pleural fluid turnover is estimated to be approximately 0.15 mL.kg-1.h-1. Pleural fluid is produced at parietal pleural level, mainly in the less dependent regions of the cavity. Reabsorption is accomplished by parietal pleural lymphatics in the most dependent part of the cavity, on the diaphragmatic surface and in the mediastinal regions. The flow rate in pleural lymphatics can increase in response to an increase in pleural fluid filtration, acting as a negative feedback mechanism to control pleural liquid volume. Such control is very efficient, as a 10 fold increase in filtration rate would only result in a 15% increase in pleural liquid volume. When filtration exceeds maximum pleural lymphatic flow, pleural effusion occurs: as an estimate, in man, maximum pleural lymph flow could attain 30 mL.h-1, equivalent to approximately 700 mL.day-1 (approximately 40% of overall lymph flow). Under physiological conditions, the lung interstitium and the pleural space behave as functionally independent compartments, due to the low water and solute permeability of the visceral pleura. Pleural fluid circulates in the pleural cavity and intrapleural fluid dynamics may be represented by a porous flow model. Lubrication between lung and chest wall is assured by oligolamellar surfactant molecules stratified on mesothelial cells of the opposing pleurae. These molecules carry a charge of similar sign and, therefore, repulse each other, assuring a graphite-like lubrication.

This article has been cited by other articles:

				V. K. Kouritas, C. Hatzoglou, C. N. Foroulis, and K. I. Gourgoulianis Human parietal pleura present electrophysiology variations according to location in pleural cavity Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 544 - 547. [Abstract] [Full Text] [PDF]

				I M Balfour-Lynn, E Abrahamson, G Cohen, J Hartley, S King, D Parikh, D Spencer, A H Thomson, D Urquhart, and on behalf of the Paediatric Pleural Diseases Subco BTS guidelines for the management of pleural infection in children Thorax, February 1, 2005; 60(suppl_1): i1 - i21. [Full Text] [PDF]

				S. J. LAI-FOOK Pleural Mechanics and Fluid Exchange Physiol Rev, April 1, 2004; 84(2): 385 - 410. [Abstract] [Full Text] [PDF]

				E. Marchi, L. R. Teixeira, F. Vargas, P. Astoul, A. Fraticelli, A. Robaglia-Schlupp, and P. Cau Talc for Pleurodesis: Hero or Villain? Chest, July 1, 2003; 124(1): 416 - 417. [Full Text] [PDF]

				G Antunes, E Neville, J Duffy, and N Ali BTS guidelines for the management of malignant pleural effusions Thorax, May 1, 2003; 58(90002): ii29 - 38. [Full Text]

				L. Zocchi Physiology and pathophysiology of pleural fluid turnover Eur. Respir. J., December 1, 2002; 20(6): 1545 - 1558. [Abstract] [Full Text] [PDF]

				Z. Borok and A. S. Verkman Lung Edema Clearance: 20 Years of Progress: Invited Review: Role of aquaporin water channels in fluid transport in lung and airways J Appl Physiol, December 1, 2002; 93(6): 2199 - 2206. [Abstract] [Full Text] [PDF]

				I. Mitrouska and D. Bouros The Trans-Exudative Pleural Effusion Chest, November 1, 2002; 122(5): 1503 - 1505. [Full Text] [PDF]

				A H Thomson, J Hull, M R Kumar, C Wallis, and I M Balfour Lynn Randomised trial of intrapleural urokinase in the treatment of childhood empyema Thorax, April 1, 2002; 57(4): 343 - 347. [Abstract] [Full Text] [PDF]

				A. D'Alessandro, G. Muzi, A. Monaco, S. Filiberto, A. Barboni, and G. Abbritti Yellow nail syndrome: does protein leakage play a role? Eur. Respir. J., January 1, 2001; 17(1): 149 - 152. [Abstract] [Full Text] [PDF]

				Y. Song, B. Yang, M. A. Matthay, T. Ma, and A. S. Verkman Role of aquaporin water channels in pleural fluid dynamics Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1744 - C1750. [Abstract] [Full Text] [PDF]

				M. NOPPEN, M. DE WAELE, R. LI, K. V. GUCHT, J. D'HAESE, E. GERLO, and W. VINCKEN Volume and Cellular Content of Normal Pleural Fluid in Humans Examined by Pleural Lavage Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 1023 - 1026. [Abstract] [Full Text]

				Leukotriene-receptor antagonists and related compounds Can. Med. Assoc. J., November 1, 1999; 161(90111): s31 - 34. [Full Text]

				C. HERMANS, O. LESUR, B. WEYNAND, TH. PIETERS, M. LAMBERT, and A. BERNARD Clara Cell Protein (CC16) in Pleural Fluids . A Marker of Leakage through the Visceral Pleura Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 962 - 969. [Abstract] [Full Text] [PDF]

				O Eickelberg, C. Sommerfeld, C Wyser, M Tamm, F Reichenberger, P. Bardin, M Soler, M Roth, and A. Perruchoud MMP and TIMP expression pattern in pleural effusions of different origins Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1987 - 1992. [Abstract] [Full Text]